Research and Practice in Thrombosis and Haemostasis
Publisher: Elsevier · ISSN 2475-0379 · 99 articles
- Platelet-released polyphosphate controls thrombin generation
- Factor XI and XIa inhibitors: defining their role and considering their implementation
- Assessment of the residual bleeding burden in hemophilia B on factor IX prophylaxis
- Free factor XIII-B in atypical hemolytic uremic syndrome: a remission signal
- Will this be the last study in previously untreated patients (PUPs) with hemophilia?
- Microplastics, nanoplastics, and thrombogenesis
- Next-generation activated factor VIII mimetics: real innovation or more of the same?
- Breaking the ice: cryopreservation of platelets in modern transfusion practice
- Impact of an integrated hospital-community care pathway on the management of venous thromboembolism: the venous thromboembolic disease care pathway 93 study
- Hetrombopag in promoting platelet engraftment after hematopoietic stem cell transplantation: a multicenter, single-arm, phase 2 study
- Early outcomes after venous thromboembolism in Hispanic and non-Hispanic patients: insights from the Registro Informatizado de Enfermedad TromboEmbólica Registry
- Association between coffee consumption and risk of recurrent venous thromboembolism – Results from the Trøndelag Health Study and Tromsø Study
- Elevated relative risk of venous thrombosis in young adults with colorectal cancer: a global cohort study
- Quantitative point-of-care testing in patients treated with apixaban
- DOACs in the Emergency Department: When No Monitoring Becomes a Clinical Challenge
- Mouse models to study von Willebrand factor in thrombosis: a scoping review
- Association of dual-pathway antithrombotic therapy with primary patency after iliofemoral venous stenting: a multicenter cohort study
- Inhibitor relapse after successful immune tolerance induction in children with severe hemophilia A: risk factors and development of a prediction nomogram
- Interplatform discrepancies in anticardiolipin and anti-beta-2-glycoprotein-I testing and their impact on antiphospholipid syndrome assessment: a retrospective-prospective observational study
- Abnormal lipid profiles are associated with markers of impaired fibrinolysis in patients with cirrhosis
- Association of the sarcopenia index based on the serum creatinine to cystatin C ratio and genetic risk with venous thromboembolism: a population-based cohort study
- A screening assay for type 2B von Willebrand factor variants using an enzyme-linked immunosorbent assay based on recombinant wild-type glycoprotein Ib and ristocetin
- Clinical significance of symptomatic and incidental venous thromboembolism in patients with cancer treated with apixaban
- Long-term outcomes of antithrombotic treatment for retinal vein occlusion
- Bleeding events in people with hemophilia B on prophylactic factor IX treatment: a systematic review and meta-analysis
- Evolutionary constraint and population variation across coagulation genes
- Prevalence of qualitative platelet disorders in adolescents and young adults with heavy menstrual bleeding: a single center experience
- Treatment patterns and safety outcomes after splenectomy or thrombopoietin receptor agonists as second-line therapy for immune thrombocytopenia: Korean claims-based study
- Reevaluating hypercoagulability in the portal vein and the impact of transjugular intrahepatic portosystemic shunt on platelet activation in cirrhosis
- A buffer-positive serotonin release assay pattern is associated with increased mortality in HIT: a retrospective cohort study